Who
Michelle LeRoux Williams
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Elutia; Chief Scientific Officer, Osiris Therapeutics.
In numbers
- Trades disclosed
- 86
- Buys
- 1
- Sells
- 4
- Bought
- $208
- Sold
- $1.3M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 4 Feb 2008
- Last trade
- 10 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $3,4154,269 at $0.80 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $3,4154,269 at $0.80 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $4,4404,269 at $1.04 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Jun 2026filed 12 Jun 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $4,4404,269 at $1.04 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $5,0284,613 at $1.09 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code M | —12,500 | filing |
| 10 Mar 2026filed 12 Mar 2026 | ELUT ElutiaBiotechnology | SEC FORM 4 Code F | $5,0284,613 at $1.09 | filing |
| 1 Jan 2026filed 5 Jan 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —368,000 at $0.00 | filing |
| 1 Jan 2026filed 5 Jan 2026 | ELUT Elutiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —368,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.